147 related articles for article (PubMed ID: 23060301)
21. Surfactant Protein A and Napsin A in the Immunohistochemical Characterization of Canine Pulmonary Carcinomas: Comparison With Thyroid Transcription Factor-1.
Beck J; Miller MA; Frank C; DuSold D; Ramos-Vara JA
Vet Pathol; 2017 Sep; 54(5):767-774. PubMed ID: 28578631
[TBL] [Abstract][Full Text] [Related]
22. Co-localisation of Glandular and Squamous Cell Markers in Non-small Cell Lung Cancer.
Koyi H; Brandén E; Kasim I; Wilander E
Anticancer Res; 2018 Jun; 38(6):3341-3346. PubMed ID: 29848682
[TBL] [Abstract][Full Text] [Related]
23. A study of immunohistochemical differential expression in pulmonary and mammary carcinomas.
Yang M; Nonaka D
Mod Pathol; 2010 May; 23(5):654-61. PubMed ID: 20173733
[TBL] [Abstract][Full Text] [Related]
24. Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis.
Nicholson AG; Gonzalez D; Shah P; Pynegar MJ; Deshmukh M; Rice A; Popat S
J Thorac Oncol; 2010 Apr; 5(4):436-41. PubMed ID: 20068475
[TBL] [Abstract][Full Text] [Related]
25. Genetic and Immunohistochemical Studies Investigating the Histogenesis of Neuroendocrine and Carcinomatous Components of Combined Neuroendocrine Carcinoma.
Iijima M; Yokobori T; Mogi A; Shimizu K; Yajima T; Kosaka T; Ohtaki Y; Obayashi K; Nakazawa S; Gombodorj N; Tsukagoshi M; Shirabe K; Kuwano H
Ann Surg Oncol; 2019 Jun; 26(6):1744-1750. PubMed ID: 30924018
[TBL] [Abstract][Full Text] [Related]
26. Spindle cell and pleomorphic ("sarcomatoid") carcinomas of the lung: an immunohistochemical analysis of 86 cases.
Weissferdt A; Kalhor N; Rodriguez Canales J; Fujimoto J; Wistuba II; Moran CA
Hum Pathol; 2017 Jan; 59():1-9. PubMed ID: 27569293
[TBL] [Abstract][Full Text] [Related]
27. Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens.
Khayyata S; Yun S; Pasha T; Jian B; McGrath C; Yu G; Gupta P; Baloch Z
Diagn Cytopathol; 2009 Mar; 37(3):178-83. PubMed ID: 19170169
[TBL] [Abstract][Full Text] [Related]
28. A study of ΔNp63 expression in lung non-small cell carcinomas.
Nonaka D
Am J Surg Pathol; 2012 Jun; 36(6):895-9. PubMed ID: 22367298
[TBL] [Abstract][Full Text] [Related]
29. Combined high-grade neuroendocrine carcinoma of the lung: clinicopathological and immunohistochemical study of 34 surgically resected cases.
Yamada K; Maeshima AM; Tsuta K; Tsuda H
Pathol Int; 2014 Jan; 64(1):28-33. PubMed ID: 24471967
[TBL] [Abstract][Full Text] [Related]
30. The role of Napsin-A and Desmocollin-3 in classifying poorly differentiating non-small cell lung carcinoma.
Ezzat Nel-S; Tahoun N
J Egypt Natl Canc Inst; 2016 Mar; 28(1):13-22. PubMed ID: 26710975
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical analysis and comparison of napsin A, TTF1, SPA and CK7 expression in primary lung adenocarcinoma.
Jin L; Liu Y; Wang X; Qi X
Biotech Histochem; 2018; 93(5):364-372. PubMed ID: 29956575
[TBL] [Abstract][Full Text] [Related]
32. New immunohistochemical markers in the differential diagnosisof nonsmall cell lung carcinoma.
Bir F; Çeliker D; Evyapan BF; Yaren A; Edirne T
Turk J Med Sci; 2016 Dec; 46(6):1854-1861. PubMed ID: 28081338
[TBL] [Abstract][Full Text] [Related]
33. Colorectal poorly differentiated neuroendocrine carcinomas and mixed adenoneuroendocrine carcinomas: insights into the diagnostic immunophenotype, assessment of methylation profile, and search for prognostic markers.
La Rosa S; Marando A; Furlan D; Sahnane N; Capella C
Am J Surg Pathol; 2012 Apr; 36(4):601-11. PubMed ID: 22314183
[TBL] [Abstract][Full Text] [Related]
34. Cervical Carcinomas With Neuroendocrine Differentiation: A Report of 28 Cases With Immunohistochemical Analysis and Molecular Genetic Evidence of Common Clonal Origin With Coexisting Squamous and Adenocarcinomas.
Emerson RE; Michael H; Wang M; Zhang S; Roth LM; Cheng L
Int J Gynecol Pathol; 2016 Jul; 35(4):372-84. PubMed ID: 26630233
[TBL] [Abstract][Full Text] [Related]
35. The value of desmosomal plaque-related markers to distinguish squamous cell carcinoma and adenocarcinoma of the lung.
Galindo I; Gómez-Morales M; Díaz-Cano I; Andrades Á; Caba-Molina M; Miranda-León MT; Medina PP; Martín-Padron J; Fárez-Vidal ME
Ups J Med Sci; 2020 Feb; 125(1):19-29. PubMed ID: 31809668
[No Abstract] [Full Text] [Related]
36. p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas?
Pelosi G; Pasini F; Olsen Stenholm C; Pastorino U; Maisonneuve P; Sonzogni A; Maffini F; Pruneri G; Fraggetta F; Cavallon A; Roz E; Iannucci A; Bresaola E; Viale G
J Pathol; 2002 Sep; 198(1):100-9. PubMed ID: 12210069
[TBL] [Abstract][Full Text] [Related]
37. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6.
Mukhopadhyay S; Katzenstein AL
Am J Surg Pathol; 2011 Jan; 35(1):15-25. PubMed ID: 21164283
[TBL] [Abstract][Full Text] [Related]
38. Cytokeratins and lung carcinomas.
Nhung NV; Mirejovský P; Mirejovský T; Melínová L
Cesk Patol; 1999 Jul; 35(3):80-4. PubMed ID: 11038661
[TBL] [Abstract][Full Text] [Related]
39. Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung.
Ye J; Findeis-Hosey JJ; Yang Q; McMahon LA; Yao JL; Li F; Xu H
Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):313-7. PubMed ID: 21464700
[TBL] [Abstract][Full Text] [Related]
40. Amplification of FGFR1 gene and expression of FGFR1 protein is found in different histological types of lung carcinoma.
Sousa V; Reis D; Silva M; Alarcão AM; Ladeirinha AF; d'Aguiar MJ; Ferreira T; Caramujo-Balseiro S; Carvalho L
Virchows Arch; 2016 Aug; 469(2):173-82. PubMed ID: 27194548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
